TickerFiles

Beta Bionics, Inc. 10-Q filing

Filed 2025-10-28 · Report date 2025-09-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001193125-25-253538
Form type
10-Q
CIK
0001674632
Primary document
https://www.sec.gov/Archives/edgar/data/1674632/000119312525253538/bbnx-20250930.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Beta Bionics, Inc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$68.1M--
Cost Of Revenue$31.5M--
Gross Profit$36.6M--
Operating Income$-55.6M--
Net Income$-59.7M--
Eps Basic-1.52--
Eps Diluted-1.52--
Cash And Equivalents$38.5M--
Total Assets$330.0M--
Total Liabilities$35.3M--
Shareholders Equity$294.8M--
Operating Cash Flow$-42.3M--
Capital Expenditures$3.4M--